HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Alternate Cosmetics Bill Pushed Back; ECHA Finds Unapproved Animal Tests; More

This article was originally published in The Rose Sheet

Executive Summary

An awaited alternative to the controversial Personal Care Products Safety Act is now expected to emerge after Congress's summer recess, ICMAD President Pam Busiek says. More news in brief.

You may also be interested in...



House Cosmetics Bill Imminent With Small – And Big – Business Support

A second bill to enhance FDA's oversight of the cosmetics industry is expected to be introduced in the next few weeks, according to Independent Cosmetic Manufacturers and Distributors President and CEO Pam Busiek. The bill will launch in the House – likely with bipartisan support – and be modeled after 2012's Cosmetic Safety Amendments Act, she said.

In Brief: NPD On Cosmetic Shoppers; African Beauty Market; Avon’s FY 2014

The NPD Group reports a 4% decline in U.S. beauty shoppers in 2014; Avon releases its fiscal 2014 results, while Energizer announces its personal-care spinoff will be called Edgewell Personal Care. More news in brief.

ECHA May Be Stickler In 2018 For ‘Last Resort’ Animal Tests Only

Requests for firms’ rationale behind animal tests and referrals to EU members states to investigate possible noncompliance may be more frequent under REACH going forward, following a European Ombudsman decision finding the European Chemicals Agency’s interpretation of its related duties “excessively restrictive.” PETA UK lodged a complaint in 2012 charging ECHA with maladministration of REACH, specifically the “last resort” principle for animal experimentation.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel